By
Martin Abeloff, MD, Eli Kennerly Marshall Jr. Professor and Chairman, Department of Oncology, The John Hopkins University School of Medicine, Oncologist-in-Chief,
The John Hopkins Hospital and Health System, Baltimore, MD
Martin Abeloff, MD, Eli Kennerly Marshall Jr. Professor and Chairman, Department of Oncology, The John Hopkins University School of Medicine, Oncologist-in-Chief,
The John Hopkins Hospital and Health System, Baltimore, MD
James Armitage, MD, Henry J. Lehnhoff Professor and Chairman, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
John Niederhuber, MD, Director, University of Wisconsin Comprehensive Cancer Center, Assistant Dean for Oncology, Wattawa Professor-Bascom, Departments
of Surgery and Oncology, University of Wisconsin Medical School, Madison, WI
Michael Kastan, MD, PhD, Chair, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN
James Armitage, MD, Henry J. Lehnhoff Professor and Chairman, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
Joel Tepper, MD,
Hector MacLean Distinguished Professor of Cancer Research
Department of Radiation Oncology
UNC Lineberger Comprehensive Cancer
Center
University of North Carolina School of Medicine
Chapel Hill, North Carolina
John Niederhuber, MD, Director, University of Wisconsin Comprehensive Cancer Center, Assistant Dean for Oncology, Wattawa Professor-Bascom, Departments
of Surgery and Oncology, University of Wisconsin Medical School, Madison, WI
James Doroshow, James H. Doroshow, M.D., National Cancer Institute, Laboratory of Molecular Pharmacology, Head, Oxidative Signaling and Molecular Therapeutics Section, Senior Investigator
Michael Kastan, MD, PhD, Chair, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN
W. McKenna, MD, PhD, Henry K. Pancoast Professor and Chairman, Radiation Oncology, University of Pennsylvania Health System, Philadelphia, PA
Daniel von Hoff, Daniel Von Hoff, M.D., F.A.C.P.
Description
Carrying on the tradition established by its founding editor, the late Dr. Martin Abeloff, the 4th Edition of this respected reference
synthesizes all of the latest oncology knowledge using a practical, clinically focused, easy-to-use approach. It incorporates basic science,
pathology, diagnosis, management, outcomes, rehabilitation, and prevention all in one convenient resource – equipping you to overcome
your toughest clinical challenges. What's more, you can access the complete contents of this Expert Consult Premium Edition online, plus
regular updates to keep your practice current . . . board-style self-assessment questions . . . downloadable illustrations . . . and
many other advanced features that make it even more indispensable for your practice!
Audience:
Medical Oncology, Radiation Oncology, Surgical Oncology.
